Format

Send to:

Choose Destination
See comment in PubMed Commons below
Alzheimers Dement. 2014 Oct;10(5 Suppl):S284-9. doi: 10.1016/j.jalz.2013.09.013. Epub 2014 Jan 15.

Familial benign frontotemporal deterioration with C9ORF72 hexanucleotide expansion.

Author information

  • 1Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain. Electronic address: egomezt@fjd.es.
  • 2Department of Neurology, Hospital Severo Ochoa, Madrid, Spain.
  • 3Secugen S.L., Madrid, Spain.
  • 4Department of Neurology, Fundación Jiménez Díaz, Madrid, Spain.

Abstract

BACKGROUND:

In recent years, a benign variant of frontotemporal lobar degeneration (FTLD) has been recognized, with a particularly slow progression of cognitive deficits and scarce frontotemporal atrophy or hypoperfusion in neuroimaging studies. Patients with FTLD have been considered "phenocopies," with an underlying nondegenerative neurologic process.

RESULTS:

We report the first family with three affected members having benign FTLD associated with C9ORF72 gene hexanucleotide expansion. Onset of symptoms occurred during the fifth decade, with naming and memory problems as the main features. Two siblings have stabilized at mild cognitive impairment or incipient dementia for more than a decade, and remain quite independent for their activities of daily living at the current ages of 69 and 65 years, respectively. Their mother's cognitive deterioration evolved slowly during >30 years.

CONCLUSION:

This family demonstrates that a benign evolution can be part of the growing spectrum of clinical phenotypes associated with neurodegenerative diseases caused by the C9ORF72 hexanucleotide expansion. Screening of this genetic marker should be considered in cases with this slow deterioration, especially if there is a family history.

Copyright © 2014 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

KEYWORDS:

C9ORF72 gene; Frontotemporal dementia; Hexanucleotide expansion; Neurogenetics

PMID:
24439166
[PubMed - in process]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk